These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


261 related items for PubMed ID: 4171697

  • 1. [On the problem of immunobiologic relations between lupus erythematosus disseminatus and progressive scleroderma].
    Meyer zum Büschenfelde, Talke H, Holzmann H.
    Arch Klin Exp Dermatol; 1967; 228(4):396-407. PubMed ID: 4171697
    [No Abstract] [Full Text] [Related]

  • 2. [Our experience in the study of nuclear and antinuclear constituant antibodies in rheumatology].
    Kahn MF, Dryll A, de Seze S.
    J Belge Rhumatol Med Phys; 1967; 22(4):217-30. PubMed ID: 4185873
    [No Abstract] [Full Text] [Related]

  • 3. [Antinuclear factors in psoriasis vulgaris and psoriasis arthropathica?].
    Meyer zum Büschenfelde.
    Arch Klin Exp Dermatol; 1968; 233(1):59-62. PubMed ID: 4177789
    [No Abstract] [Full Text] [Related]

  • 4. [The fall of blood complement level in pathology. Study of 50 cases].
    Kourilsky O, Peltier AP, de Sèze S.
    Nouv Presse Med; 1972 Jul 08; 1(28):1883-8. PubMed ID: 4115492
    [No Abstract] [Full Text] [Related]

  • 5. [Differentiation with immunofluorescence of complement fixing and non-fixing antinuclear factors in patients with and without disseminated lupus erythematosus].
    Peltier AP.
    Pathol Biol; 1968 Apr 08; 16(7):439-44. PubMed ID: 4882383
    [No Abstract] [Full Text] [Related]

  • 6. Serum antinuclear antibodies in progressive systemic sclerosis (scleroderma).
    Rothfield NF, Rodnan GP.
    Arthritis Rheum; 1968 Oct 08; 11(5):607-17. PubMed ID: 4176069
    [No Abstract] [Full Text] [Related]

  • 7. The clinical significance of titered antinuclear antibodies.
    Ritchie RF.
    Arthritis Rheum; 1967 Dec 08; 10(6):544-52. PubMed ID: 4864485
    [No Abstract] [Full Text] [Related]

  • 8. [Antinuclear antibodies in systemic lupus erythematosus before and after treatment and in chronic progressive polyarthritis. Some observations on the antiperinuclear factor].
    Marmont A, Damasio E.
    J Belge Rhumatol Med Phys; 1967 Dec 08; 22(4):236-66. PubMed ID: 4185874
    [No Abstract] [Full Text] [Related]

  • 9. Cytotoxins in disease. Autocytotoxins in lupus.
    Terasaki PI, Mottironi VD, Barnett EV.
    N Engl J Med; 1970 Oct 01; 283(14):724-8. PubMed ID: 5311527
    [No Abstract] [Full Text] [Related]

  • 10. [The problems of autoimmunization as basis of the so-called collagenoses].
    Sönnichsen N.
    Z Gesamte Inn Med; 1969 Jan 01; 24(1):Suppl:140-4. PubMed ID: 5311832
    [No Abstract] [Full Text] [Related]

  • 11. Comparative evaluation of antinuclear factor tests in rheumatic disorders.
    Willkens RF, Decker JL, Wilske KR.
    Med Clin North Am; 1968 May 01; 52(3):559-65. PubMed ID: 4385202
    [No Abstract] [Full Text] [Related]

  • 12. Antinuclear factor in rheumatoid arthritis and related diseases.
    Pitkeathly DA, Taylor G.
    Ann Rheum Dis; 1967 Jan 01; 26(1):1-9. PubMed ID: 4163368
    [No Abstract] [Full Text] [Related]

  • 13. Comparison of the complement-fixing activity of antinuclear antibodies in lupus nephritis, mixed connective tissue disease, and scleroderma.
    Parker MD, Turner RA.
    Arthritis Rheum; 1976 Jan 01; 19(5):857-61. PubMed ID: 786297
    [Abstract] [Full Text] [Related]

  • 14. Anti-nuclear factors in rheumatoid arthritis, systemic lupus erythematosus and other diseases. Re-evaluation of the nucleoprotein complement fixation technique and anti-complementary activity.
    Onodera S, Schubart AF, Ewald RW, Heuckenkamp PU.
    J Chronic Dis; 1966 Jan 01; 19(11):1133-44. PubMed ID: 5297998
    [No Abstract] [Full Text] [Related]

  • 15. Philip Ellman lecture. Immunological aspects of systemic diseases of the lungs.
    Turner-Warwick M.
    Proc R Soc Med; 1974 Jun 01; 67(6 Pt 2):541-7. PubMed ID: 4152998
    [No Abstract] [Full Text] [Related]

  • 16. [Autoantibodies in collagen diseases].
    Meyer O.
    Ann Med Interne (Paris); 1986 Jun 01; 137(8):666-78. PubMed ID: 2436515
    [No Abstract] [Full Text] [Related]

  • 17. Urinary immunoglobulins in rheumatoid arthritis and other connective tissue diseases.
    Lindström FD.
    Ann Clin Res; 1971 Feb 01; 3(1):39-45. PubMed ID: 4100602
    [No Abstract] [Full Text] [Related]

  • 18. Association of autoantibodies to different nuclear antigens with clinical patterns of rheumatic disease and responsiveness to therapy.
    Sharp GC, Irvin WS, LaRoque RL, Velez C, Daly V, Kaiser AD, Holman HR.
    J Clin Invest; 1971 Feb 01; 50(2):350-9. PubMed ID: 4992992
    [Abstract] [Full Text] [Related]

  • 19. [Antinuclear factors. Demonstration and clinico-diagnostic significance].
    Maas D.
    Med Klin; 1969 Jul 18; 64(29):1302-7. PubMed ID: 4184549
    [No Abstract] [Full Text] [Related]

  • 20. [Antinuclear, anticentromere and anti-ScL-70 antibodies in rheumatic diseases].
    Ivanova SM, Melkumova KL, Il'in KV, Riazantseva TA, Piven' VA, Speranskiĭ AI.
    Lab Delo; 1990 Jul 18; (6):50-3. PubMed ID: 1699041
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 14.